News | April 30, 2007

Hansen Teams Robotics With St. Jude EP Mapping System

May 1, 2007 — Hansen Medical Inc., a developer of robotic technology for accurate 3D control of catheter movement during cardiac procedures, has announced it has entered into joint development and co-marketing agreements with St. Jude Medical of St. Paul, MN, a global leader of electrophysiology (EP) technology, to integrate technologies from its Sensei Robotic Catheter System and Artisan Control Catheter with St. Jude Medical's EnSite System.

The first generation robotic platform from Hansen Medical is designed to allow physicians to place mapping catheters in hard-to-reach anatomical locations within the heart more easily, accurately and with greatly increased stability as compared to existing manual technique. The Sensei Robotic Catheter System has received CE mark in Europe, and the Artisan Control Catheter is currently pending CE mark approval. Additionally, the Sensei System is pending U.S. FDA clearance.

The EnSite system is a computer-based technology marketed worldwide that facilitates EP procedures by creating real-time 3D graphical displays or maps of cardiac structures and arrhythmias. These maps are designed to provide the visual guidance necessary to navigate catheters used during EP procedures. Previously, two-dimensional technologies such as fluoroscopy or ultrasound were used to assist physicians with guiding catheters inside the heart, which is a three-dimensional space.

Combining the Sensei and EnSite technologies is intended to provide physicians with 3D visualization that will augment their ability to confidently move a catheter throughout the heart, as well as greatly increase control over placement of the catheter in specific locations.

The Sensei system is adaptable to any existing EP procedure room and the mobile workstation can be placed away from direct radiation. In addition to lessening operator fatigue, the remote placement of the workstation creates a virtual shield for physicians against harmful radiation during catheter-based EP procedures.

The EnSite System is used by EP clinicians during EP procedures to create 3D models of their patients' cardiac anatomy and then to visualize catheters used in those procedures as they are navigated to critical anatomical targets. The system collects and organizes activation and voltage data from the inner surface of the heart, which allows physicians to visualize arrhythmias on the 3D model and more easily determine a treatment strategy.

The joint development and worldwide co-marketing agreements between St. Jude Medical and Hansen Medical are two-year agreements. Under the terms of the joint development agreement, St. Jude Medical and Hansen Medical will exclusively co-develop technology that will enable the integration of the Sensei and Ensite Systems. Under the terms of the co-marketing agreement, St. Jude Medical has exclusive co-marketing rights to market the Sensei System with St. Jude Medical products in targeted EP accounts.

For more information visit www.hansenmedical.com.

Related Content

Computer Simulations May Treat Most Common Heart Rhythm Disorder

The OPTIMA (Optimal Target Identification via Modelling of Arrhythmogenesis) simulator uses contrast-enhanced MRI scans to create personalized digital replicas of a patient's heart to guide catheter abation for atrial fibrillation. Image courtesy of Patrick M. Boyle and Natalia A. Trayanova.

News | EP Mapping and Imaging Systems | August 19, 2019
Scientists at Johns Hopkins have successfully created personalized digital replicas of the upper chambers of the heart...
Charge Density Mapping Eliminates Repeat Ablation for Atrial Fibrillation at One Year
News | EP Mapping and Imaging Systems | July 15, 2019
Acutus Medical announced the publication of the UNCOVER AF study in Circulation: Arrhythmia and Electrophysiology. The...
Innovative Health Receives FDA Clearance to Reprocess Pentaray Nav Eco High-density Mapping Catheter
News | EP Mapping and Imaging Systems | July 05, 2019
Single-use cardiology medical device reprocessing company Innovative Health, received U.S. Food and Drug Administration...
VIVO 3-D Cardiac Mapping System Cleared by FDA
Technology | EP Mapping and Imaging Systems | July 01, 2019
Catheter Precision Inc. announced that the U.S. Food and Drug Administration (FDA) has cleared its new VIVO (View into...
Algorithm Steers Catheters to Right Spot to Treat Atrial Fibrillation

Using human AFib simulations, the researchers demonstrated that their technique can stop the catheter at the right target and identify the source type with a 95.25 percent success rate. This new algorithm also is effective in scarred tissue, which makes ablation more challenging, and has a 99 percent detection rate regardless of the scar size. Image courtesy of Florida Atlantic University.

News | EP Mapping and Imaging Systems | May 28, 2019
Researchers have developed the first algorithm that can locate patient-specific ablation targets for atrial...
Acutus Medical Announces Rhythm Xience Acquisition, New Partnerships at HRS 2019

Acutus Medical's acquisition of Rhythm Xience brings the Flextra steerable introducer sheath into Acutus Medical's product portfolio.

News | EP Mapping and Imaging Systems | May 17, 2019
At the 40th annual Heart Rhythm Scientific Sessions, May 8-11 in San Francisco, Acutus Medical announced the agreement...
Electromechanical Wave Imaging (EWI) is a new, high-frame rate 3-D rendered ultrasound technique that can noninvasively map the electromechanical activation of heart rhythm. This example shows the ECG tracings compared to the EWI image of the heart.

Electromechanical Wave Imaging (EWI) is a new, high-frame rate 3-D rendered ultrasound technique that can noninvasively map the electromechanical activation of heart rhythm. This example shows the ECG tracings compared to the EWI image of the heart.

Feature | EP Mapping and Imaging Systems | May 15, 2019 | Dave Fornell, Editor
May 15, 2019 — A new study shows electromechanical wave imaging is capable of localizing arrhythmias including atrial
Philips and Medtronic Collaborate on Image-guided Atrial Fibrillation Treatment
News | EP Mapping and Imaging Systems | May 09, 2019
Philips announced a collaboration with Medtronic to further advance treatment of paroxysmal atrial fibrillation (PAF),...
Acutus Medical Receives FDA Clearance for Second-generation AcQMap Platform
Technology | EP Mapping and Imaging Systems | April 26, 2019
Acutus Medical announced U.S. Food and Drug Administration (FDA) clearance of its second-generation AcQMap platform,...
Acutus AcQMap Imaging System Helps Eliminate Arrhythmia With Single Ablation
News | EP Mapping and Imaging Systems | January 28, 2019
Acutus Medical announced 12-month data from the UNCOVER-AF trial investigating the use of the AcQMap advanced cardiac...
Overlay Init